Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Large Cap

Large Cap

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Contracts
  • Equities
  • Large Cap
  • Markets
  • News

Powering Up America’s Heartland: Kokomo Chosen For Stellantis-Samsung SDI’s Second US StarPlus Energy Gigafactory

By Lekha Gupta
October 11, 9:28 AM
Stellantis N.V. (NYSE: STLA), in a joint venture with Samsung SDI, disclosed Kokomo, Indiana, as the second site for the electric vehicle battery 

STLA

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Legal
  • News

Little Less Heartburn For GSK: Settles Another California Lawsuit On Zantac

By Vandana Singh
October 11, 9:26 AM
GSK plc (NYSE: GSK) has reached a confidential settlement in the Cantlay/Harper case filed in California state court. 

GSK

Read More
1 minute read
  • Equities
  • Large Cap
  • Management
  • Markets
  • News

Health Insurer Humana Ropes In Former UnitedHealth Executive To Assume CEO Role In 2024

By Lekha Gupta
October 11, 8:27 AM
Humana Inc (NYSE: HUM) disclosed the appointment of healthcare industry veteran Jim Rechtin as President and Chief Operating Officer, 

HUM

Read More
1 minute read
  • Earnings
  • Equities
  • Large Cap
  • Markets
  • Media
  • News

Samsung Electronics To Report Above-Consensus Q3 Profits Reflecting Hopes On Chip Recovery

By Lekha Gupta
October 11, 8:11 AM
Samsung Electronics Co Ltd (OTC: SSNLF) reported 

SSNLF

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Novo Nordisk Stops Semaglutide Kidney Outcome Trial Based On Early Signs Of Efficacy

By Vandana Singh
October 11, 7:48 AM
Novo Nordisk A/S (NYSE: NVO) has decided to stop&

NVO

Read More
1 minute read
  • Dividends
  • Equities
  • Guidance
  • Large Cap
  • Markets
  • News

HP Raises Annual Dividend by 5%, Provides FY24 Outlook & More

By Lekha Gupta
October 11, 6:50 AM
HP Inc (NYSE: HPQ) provided an FY24 outlook, updated on its cost saving initiatives, and raised its annual dividend. 

HPQ

Read More
1 minute read
  • Earnings
  • Equities
  • Guidance
  • Large Cap
  • Markets
  • News

French Fashion Giant LVMH Posts 9% Organic Revenue Growth In Q3

By Lekha Gupta
October 11, 6:00 AM
French luxury fashion house LVMH-Moet Hennessy Louis Vuitton (OTC: LVMHF) (OTC: LVMUY) reported 

LVMHF

Read More
3 minute read
  • Analyst Color
  • Analyst Ratings
  • Large Cap

US Banks Q3 Earnings Preview: Why Bank Of America Analysts Are Bullish On Financial Stocks

By Piero Cingari
October 10, 4:19 PM
Among the banks reporting earnings this week are JPMorgan Chase, BlackRock, Citigroup, Wells Fargo and PNC Financial Services.

BLK

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Equities
  • Large Cap
  • Markets
  • News
  • Price Target
  • Reiteration
  • Trading Ideas

Tractor Supply Remains A Strong Buy Despite Near-Term Concerns: Analyst’s Take

By Lekha Gupta
October 10, 1:49 PM
Raymond James analyst Bobby Griffin lowered the price target of Tractor Supply Co (NASDAQ: TSCO) to $235 from $255 and 

TSCO

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Merck’s Lead Cancer Drug Meets Primary Goal In Certain Type Of Lung Cancer Patients

By Vandana Singh
October 10, 12:30 PM
Merck & Co Inc (NYSE: MRK) reported topline data from the Phase 3 KEYNOTE-671 trial investigating Keytruda, Merck's anti-PD-1 therapy, as a perioperative treatment regimen for patients with resectable stage II, IIIA or IIIB (T3-4N2) 

MRK

Posts pagination

Previous 1 … 194 195 196 … 437 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service